← Evidence map

ArticleLancet (London, England)2017

Efficacy of infliximab biosimilars in patients with Crohn's disease.

Davide Giuseppe Ribaldone et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2017
2018
2019
2020
2021
2022
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 29208303